XML 94 R81.htm IDEA: XBRL DOCUMENT v3.6.0.2
SUBSEQUENT EVENTS (Narrative) (Details)
Feb. 14, 2017
USD ($)
Jan. 10, 2017
USD ($)
$ / shares
Feb. 06, 2017
USD ($)
institution
instrument
Dec. 31, 2016
USD ($)
instrument
$ / shares
Oct. 25, 2016
$ / shares
Jul. 12, 2016
USD ($)
Jun. 22, 2016
instrument
Dec. 31, 2015
$ / shares
Subsequent Event [Line Items]                
Common stock, par value (in dollars per share) | $ / shares       $ 0.01 $ 0.01     $ 0.01
Interest rate swap                
Subsequent Event [Line Items]                
Derivative, number of instruments | instrument       3        
Derivative, notional amount       $ 150,000,000   $ 50,000,000    
Interest rate swap | Designated as hedging instrument | Cash flow hedging                
Subsequent Event [Line Items]                
Derivative, number of instruments | instrument             2  
Derivative, notional amount       $ 150,000,000        
Subsequent Event | Interest rate swap | Designated as hedging instrument | Cash flow hedging                
Subsequent Event [Line Items]                
Derivative, number of instruments | instrument     2          
Derivative, number of financial institutions | institution     2          
Subsequent Event | Interest Rate Swap Three | Designated as hedging instrument | Cash flow hedging                
Subsequent Event [Line Items]                
Derivative, notional amount     $ 50,000,000.0          
Subsequent Event | Interest Rate Swap Four | Designated as hedging instrument | Cash flow hedging                
Subsequent Event [Line Items]                
Derivative, notional amount     $ 100,000,000          
Derma Sciences | Subsequent Event                
Subsequent Event [Line Items]                
Common stock, par value (in dollars per share) | $ / shares   $ 0.01            
Expected consideration to be transferred   $ 207,600,000            
DePuy Synthes | Subsequent Event                
Subsequent Event [Line Items]                
Expected consideration to be transferred $ 1,000,000,000              
DePuy Synthes | DePuy Synthes | Subsequent Event                
Subsequent Event [Line Items]                
Alternative transaction, percentage of assets (or more) 25.00%              
Reimbursement expense, if offer not accepted prior to expiration $ 10,500,000              
Termination fee, if requirements not met $ 41,800,000              
Termination fee due if alternate proposal accepted, period after termination of offer 12 months              
Common Stock | Derma Sciences | Subsequent Event                
Subsequent Event [Line Items]                
Share price (in dollars per share) | $ / shares   $ 7.0            
Series A Preferred Stock | Derma Sciences | Subsequent Event                
Subsequent Event [Line Items]                
Share price (in dollars per share) | $ / shares   32.00            
Series B Preferred Stock | Derma Sciences | Subsequent Event                
Subsequent Event [Line Items]                
Share price (in dollars per share) | $ / shares   $ 48.00